病例报告：与 2 型麻风反应相关的非酒精性脂肪性肝病。
Case Report: Nonalcoholic Hepatic Steatosis Associated with Type-2 Leprosy Reaction.
机构信息
Servicio de Infectología, IMAT ONCOMEDICA Auna, Montería, Columbia.
Servicio de Medicina General, IMAT ONCOMEDICA Auna, Montería, Colombia.
出版信息
Am J Trop Med Hyg. 2024 Jul 2;111(3):560-564. doi: 10.4269/ajtmh.23-0874. Print 2024 Sep 4.
Abstract
Leprosy reactions are complex immune events, generating disabling consequences and threatening the lives of those who experience them. This case report addresses the episode of a 28-year-old female patient who suffered a severe type-2 leprosy reaction, characterized by significant hepatic involvement, specifically, nonalcoholic hepatic steatosis. This case report underscores the importance of maintaining a high level of clinical suspicion, early recognition, accurate diagnosis, and immediate addressing of these types of reactions that may arise in the context of leprosy.
摘要
麻风反应是复杂的免疫事件，会产生致残后果，威胁到经历这些反应的人的生命。本病例报告介绍了一位 28 岁女性患者的发病经过，她患有严重的 2 型麻风反应，其特征是肝明显受累，具体表现为非酒精性肝脂肪变性。本病例报告强调了在麻风病背景下可能出现的这些类型反应，要保持高度的临床警惕、早期识别、准确诊断和及时处理的重要性。
相似文献
1
Case Report: Nonalcoholic Hepatic Steatosis Associated with Type-2 Leprosy Reaction.病例报告：与 2 型麻风反应相关的非酒精性脂肪性肝病。
Am J Trop Med Hyg. 2024 Jul 2;111(3):560-564. doi: 10.4269/ajtmh.23-0874. Print 2024 Sep 4.
3
The Onset of Steatosis Occurs as Early as Seven Days and Progresses to Nonalcoholic Steatohepatitis in a Pediatric Pig Model of Nonalcoholic Fatty Liver Disease.在非酒精性脂肪性肝病的小儿猪模型中，脂肪变性早在七天时就已出现，并进展为非酒精性脂肪性肝炎。
J Nutr. 2025 Jan;155(1):211-223. doi: 10.1016/j.tjnut.2024.11.009. Epub 2024 Nov 12.
4
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort.遗传风险加剧了基于人群队列的肝脂肪变性、炎症和纤维化的饮食效应。
J Hepatol. 2024 Sep;81(3):379-388. doi: 10.1016/j.jhep.2024.03.045. Epub 2024 Apr 4.
5
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病：系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
6
Exploring the Utility of High-Resolution Ultrasonography and Color Doppler of Peripheral Nerves in Monitoring Response to Treatment in Leprosy Patients: A Prospective, Observational Study.探讨高分辨率超声和周围神经彩色多普勒在监测麻风病患者治疗反应中的应用：一项前瞻性、观察性研究。
Am J Trop Med Hyg. 2024 Sep 17;111(5):1046-1050. doi: 10.4269/ajtmh.24-0256. Print 2024 Nov 6.
8
Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.耐药性（氨苯砜、利福平、氧氟沙星）与麻风病患者耐药相关基因突变特征：系统评价和荟萃分析。
Int J Mol Sci. 2022 Oct 18;23(20):12443. doi: 10.3390/ijms232012443.
9
Resolvin D5: A lipid mediator with a therapeutic effect on hepatic steatosis through SIRT6/autophagy.消退素D5：一种通过SIRT6/自噬对肝脂肪变性具有治疗作用的脂质介质。
Tissue Cell. 2025 Oct;96:102980. doi: 10.1016/j.tice.2025.102980. Epub 2025 May 17.
10
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.非酒精性脂肪肝中肝脂肪与肝损伤和胰岛素抵抗的因果关系。
J Intern Med. 2018 Apr;283(4):356-370. doi: 10.1111/joim.12719. Epub 2017 Dec 27.
本文引用的文献
1
Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.病例报告：初染后 50 年，坏死性结节红斑作为麻风复发的表现。
Am J Trop Med Hyg. 2023 May 30;109(1):53-56. doi: 10.4269/ajtmh.22-0701. Print 2023 Jul 5.
2
Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management.麻风病：流行病学、临床诊断与管理综述
J Trop Med. 2022 Jul 4;2022:8652062. doi: 10.1155/2022/8652062. eCollection 2022.
3
Mycobacterium lepromatosis as Cause of Leprosy, Colombia.麻风分枝杆菌致麻风，哥伦比亚。
Emerg Infect Dis. 2022 May;28(5):1067-1068. doi: 10.3201/eid2805.212015.
4
Leprosy Reactions and Neuropathic Pain in Pure Neural Leprosy in a Reference Center in Rio de Janeiro - Brazil.巴西里约热内卢一个参考中心的纯神经型麻风病中的麻风反应和神经性疼痛
Front Med (Lausanne). 2022 Mar 25;9:865485. doi: 10.3389/fmed.2022.865485. eCollection 2022.
5
Lucio's phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management.卢西奥现象：定义、临床特征、组织病理学发病机制和治疗的系统文献综述。
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(4):464-477. doi: 10.25259/IJDVL_909_19.
6
What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum.麻风结节性红斑的发病机制与治疗有哪些新进展。
Indian Dermatol Online J. 2020 Jul 13;11(4):482-492. doi: 10.4103/idoj.IDOJ_561_19. eCollection 2020 Jul-Aug.
7
Leprosy: Treatment and management of complications.麻风病：并发症的治疗与管理。
J Am Acad Dermatol. 2020 Jul;83(1):17-30. doi: 10.1016/j.jaad.2019.10.138. Epub 2020 Mar 31.
8
Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.抗天然辛基二糖-麻风病国际麻风病防治协会诊断（NDO-LID）抗体作为麻风反应和神经炎的指标。
Trans R Soc Trop Med Hyg. 2017 Mar 1;111(3):125-131. doi: 10.1093/trstmh/trx026.
9
The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.先天性和适应性免疫反应对麻风病不同临床结局的影响。
Infect Dis Poverty. 2017 Feb 6;6(1):5. doi: 10.1186/s40249-016-0229-3.
10
Recognizing and managing the immunologic reactions in leprosy.认识和管理麻风病中的免疫反应。
J Am Acad Dermatol. 2014 Oct;71(4):795-803. doi: 10.1016/j.jaad.2014.03.034. Epub 2014 Apr 24.
Zotero 插件